Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 40

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Structural Dynamics and Topology of Phosphorylated Phospholamban Homopentamer Reveal Its Role in the Regulation of Calcium Transport

Vostrikov, Vitaly V., Mote, Kaustubh R., Verardi, Raffaello, Veglia, Gianluigi · 2013 · Structure

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.str.2013.09.008

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Research works printed but not linked: 90

  1. Abu-Baker, 2006, Phospholamban and its phosphorylated form interact differently with lipid bilayers: a 31P, 2H, and 13C solid-state NMR spectroscopic study, Biochemistry, 45, 13312, 10.1021/bi0614028 · doi:10.1021/bi0614028
  2. Anderson, 2011, CaMKII in myocardial hypertrophy and heart failure, J. Mol. Cell. Cardiol., 51, 468, 10.1016/j.yjmcc.2011.01.012 · DOI · Paper page
  3. Aschar-Sobbi, 2012, Phospholamban phosphorylation increases the passive calcium leak from cardiac sarcoplasmic reticulum, Pflugers Arch., 464, 295, 10.1007/s00424-012-1124-9 · doi:10.1007/s00424-012-1124-9
  4. Becucci, 2009, On the function of pentameric phospholamban: ion channel or storage form?, Biophys. J., 96, L60, 10.1016/j.bpj.2009.03.013 · doi:10.1016/j.bpj.2009.03.013
  5. Becucci, 2013, Can proton pumping by SERCA enhance the regulatory role of phospholamban and sarcolipin?, Biochim. Biophys. Acta, 1828, 2682, 10.1016/j.bbamem.2013.07.012 · doi:10.1016/j.bbamem.2013.07.012
  6. Bhattacharya, 2007, Evaluating protein structures determined by structural genomics consortia, Proteins, 66, 778, 10.1002/prot.21165 · DOI · Paper page
  7. Buck, 2003, Overexpression, purification, and characterization of recombinant Ca-ATPase regulators for high-resolution solution and solid-state NMR studies, Protein Expr. Purif., 30, 253, 10.1016/S1046-5928(03)00127-X · DOI
  8. Ceholski, 2012, Lethal, hereditary mutants of phospholamban elude phosphorylation by protein kinase A, J. Biol. Chem., 287, 26596, 10.1074/jbc.M112.382713 · DOI · Paper page
  9. Chien, 2006, Beyond small molecule drugs for heart failure: prospects for gene therapy, Novartis Found. Symp., 274, 244, 10.1002/0470029331.ch15 · doi:10.1002/0470029331.ch15
  10. Chu, 1997, Monomeric phospholamban overexpression in transgenic mouse hearts, Circ. Res., 81, 485, 10.1161/01.RES.81.4.485 · DOI
  11. Chu, 2010, (15)N solid-state NMR spectroscopic studies on phospholamban at its phosphorylated form at ser-16 in aligned phospholipid bilayers, Biochim. Biophys. Acta, 1798, 312, 10.1016/j.bbamem.2009.12.020 · doi:10.1016/j.bbamem.2009.12.020
  12. Cornea, 1997, Mutation and phosphorylation change the oligomeric structure of phospholamban in lipid bilayers, Biochemistry, 36, 2960, 10.1021/bi961955q · DOI · Paper page
  13. Cornea, 2000, Reexamination of the role of the leucine/isoleucine zipper residues of phospholamban in inhibition of the Ca2+ pump of cardiac sarcoplasmic reticulum, J. Biol. Chem., 275, 41487, 10.1074/jbc.M008195200 · doi:10.1074/jbc.m008195200
  14. Cornell, 1988, Conformation and orientation of gramicidin a in oriented phospholipid bilayers measured by solid state carbon-13 NMR, Biophys. J., 53, 67, 10.1016/S0006-3495(88)83066-2 · DOI
  15. Davis, 2007, MolProbity: all-atom contacts and structure validation for proteins and nucleic acids, Nucleic Acids Res., 35, W375, 10.1093/nar/gkm216 · DOI · Paper page
  16. de Medeiros, 2010, Backbone dynamics of the antifungal Psd1 pea defensin and its correlation with membrane interaction by NMR spectroscopy, Biochim. Biophys. Acta, 1798, 105, 10.1016/j.bbamem.2009.07.013 · DOI
  17. de Planque, 2003, Protein-lipid interactions studied with designed transmembrane peptides: role of hydrophobic matching and interfacial anchoring, Mol. Membr. Biol., 20, 271, 10.1080/09687680310001605352 · DOI · Paper page
  18. Farrow, 1994, Backbone dynamics of a free and phosphopeptide-complexed Src homology 2 domain studied by 15N NMR relaxation, Biochemistry, 33, 5984, 10.1021/bi00185a040 · DOI · Paper page
  19. Fernández, 2002, Lipid-protein interactions in DHPC micelles containing the integral membrane protein OmpX investigated by NMR spectroscopy, Proc. Natl. Acad. Sci. USA, 99, 13533, 10.1073/pnas.212515099 · doi:10.1073/pnas.212515099
  20. Glaves, 2011, Phosphorylation and mutation of phospholamban alter physical interactions with the sarcoplasmic reticulum calcium pump, J. Mol. Biol., 405, 707, 10.1016/j.jmb.2010.11.014 · DOI
  21. Gor’kov, 2006, A large volume flat coil probe for oriented membrane proteins, J. Magn. Reson., 181, 9, 10.1016/j.jmr.2006.03.008 · doi:10.1016/j.jmr.2006.03.008
  22. Gustavsson, 2011, Lipid-mediated folding/unfolding of phospholamban as a regulatory mechanism for the sarcoplasmic reticulum Ca2+-ATPase, J. Mol. Biol., 408, 755, 10.1016/j.jmb.2011.03.015 · DOI · Paper page
  23. Gustavsson, 2011, Activating and deactivating roles of lipid bilayers on the Ca(2+)-ATPase/phospholamban complex, Biochemistry, 50, 10367, 10.1021/bi200759y · DOI · Paper page
  24. Gustavsson, 2012, Probing ground and excited states of phospholamban in model and native lipid membranes by magic angle spinning NMR spectroscopy, Biochim. Biophys. Acta, 1818, 146, 10.1016/j.bbamem.2011.07.040 · DOI · Paper page
  25. Gustavsson, 2013, Allosteric regulation of SERCA by phosphorylation-mediated conformational shift of phospholamban, Proc. Natl. Acad. Sci. USA, 10.1073/pnas.1303006110 · DOI · Paper page
  26. Ha, 2007, Controlling the inhibition of the sarcoplasmic Ca2+-ATPase by tuning phospholamban structural dynamics, J. Biol. Chem., 282, 37205, 10.1074/jbc.M704056200 · DOI
  27. Ha, 2011, Lethal Arg9Cys phospholamban mutation hinders Ca2+-ATPase regulation and phosphorylation by protein kinase A, Proc. Natl. Acad. Sci. USA, 108, 2735, 10.1073/pnas.1013987108 · DOI
  28. Ha, 2012, Tuning the structural coupling between the transmembrane and cytoplasmic domains of phospholamban to control sarcoplasmic reticulum Ca(2+)-ATPase (SERCA) function, J. Muscle Res. Cell Motil., 33, 485, 10.1007/s10974-012-9319-4 · DOI
  29. Hadri, 2010, SERCA2a gene transfer enhances eNOS expression and activity in endothelial cells, Mol. Ther., 18, 1284, 10.1038/mt.2010.77 · DOI
  30. Hou, 2008, Phosphomimetic mutations increase phospholamban oligomerization and alter the structure of its regulatory complex, J. Biol. Chem., 283, 28996, 10.1074/jbc.M804782200 · doi:10.1074/jbc.m804782200
  31. Hou, 2012, Crystal structure of the calcium release-activated calcium channel Orai, Science, 338, 1308, 10.1126/science.1228757 · DOI · Paper page
  32. Jarymowycz, 2006, Fast time scale dynamics of protein backbones: NMR relaxation methods, applications, and functional consequences, Chem. Rev., 106, 1624, 10.1021/cr040421p · DOI · Paper page
  33. Karim, 2004, Phospholamban structural dynamics in lipid bilayers probed by a spin label rigidly coupled to the peptide backbone, Proc. Natl. Acad. Sci. USA, 101, 14437, 10.1073/pnas.0402801101 · doi:10.1073/pnas.0402801101
  34. Kimura, 1996, Phospholamban regulates the Ca2+-ATPase through intramembrane interactions, J. Biol. Chem., 271, 21726, 10.1074/jbc.271.36.21726 · DOI
  35. Kimura, 1997, Phospholamban inhibitory function is activated by depolymerization, J. Biol. Chem., 272, 15061, 10.1074/jbc.272.24.15061 · DOI · Paper page
  36. Kimura, 1998, Phospholamban domain Ib mutations influence functional interactions with the Ca2+-ATPase isoform of cardiac sarcoplasmic reticulum, J. Biol. Chem., 273, 14238, 10.1074/jbc.273.23.14238 · DOI · Paper page
  37. King, 1990, A cleavage method which minimizes side reactions following Fmoc solid phase peptide synthesis, Int. J. Pept. Protein Res., 36, 255, 10.1111/j.1399-3011.1990.tb00976.x · DOI · Paper page
  38. Kneller, 2002, An effective method for the discrimination of motional anisotropy and chemical exchange, J. Am. Chem. Soc., 124, 1852, 10.1021/ja017461k · DOI · Paper page
  39. Kovacs, 1988, Phospholamban forms Ca2+-selective channels in lipid bilayers, J. Biol. Chem., 263, 18364, 10.1016/S0021-9258(19)81368-6 · doi:10.1016/s0021-9258(19)81368-6
  40. Kranias, 2012, Modulation of cardiac contractility by the phospholamban/SERCA2a regulatome, Circ. Res., 110, 1646, 10.1161/CIRCRESAHA.111.259754 · DOI · Paper page
  41. Landschulz, 1988, The leucine zipper: a hypothetical structure common to a new class of DNA binding proteins, Science, 240, 1759, 10.1126/science.3289117 · DOI · Paper page
  42. Li, 1998, Phosphorylation-induced structural change in phospholamban and its mutants, detected by intrinsic fluorescence, Biochemistry, 37, 7869, 10.1021/bi9801053 · doi:10.1021/bi9801053
  43. Li, 2003, Phosphorylation by cAMP-dependent protein kinase modulates the structural coupling between the transmembrane and cytosolic domains of phospholamban, Biochemistry, 42, 10674, 10.1021/bi034708c · DOI
  44. MacLennan, 2003, Phospholamban: a crucial regulator of cardiac contractility, Nat. Rev. Mol. Cell Biol., 4, 566, 10.1038/nrm1151 · DOI · Paper page
  45. Madden, 1979, Cholesterol modulates activity of calcium-dependent ATPase of the sarcoplasmic reticulum, Nature, 279, 538, 10.1038/279538a0 · DOI
  46. Marassi, 2000, A solid-state NMR index of helical membrane protein structure and topology, J. Magn. Reson., 144, 150, 10.1006/jmre.2000.2035 · DOI · Paper page
  47. Marks, 2013, Calcium cycling proteins and heart failure: mechanisms and therapeutics, J. Clin. Invest., 123, 46, 10.1172/JCI62834 · DOI · Paper page
  48. Mascioni, 2003, Theoretical analysis of residual dipolar coupling patterns in regular secondary structures of proteins, J. Am. Chem. Soc., 125, 12520, 10.1021/ja0354824 · doi:10.1021/ja0354824
  49. Medeiros, 2011, Mutations in the human phospholamban gene in patients with heart failure, Am. Heart J., 162, 1088, 10.1016/j.ahj.2011.07.028 · DOI
  50. Metcalfe, 2004, (1)H/(15)N heteronuclear NMR spectroscopy shows four dynamic domains for phospholamban reconstituted in dodecylphosphocholine micelles, Biophys. J., 87, 1205, 10.1529/biophysj.103.038844 · DOI
  51. Metcalfe, 2005, Serine 16 phosphorylation induces an order-to-disorder transition in monomeric phospholamban, Biochemistry, 44, 4386, 10.1021/bi047571e · DOI
  52. Naim, 2013, Gene therapy for heart failure: where do we stand?, Curr. Cardiol. Rep., 15, 333, 10.1007/s11886-012-0333-3 · DOI
  53. Nilges, 1997, Ambiguous distance data in the calculation of NMR structures, Fold. Des., 2, S53, 10.1016/S1359-0278(97)00064-3 · doi:10.1016/s1359-0278(97)00064-3
  54. Oxenoid, 2005, The structure of phospholamban pentamer reveals a channel-like architecture in membranes, Proc. Natl. Acad. Sci. USA, 102, 10870, 10.1073/pnas.0504920102 · DOI · Paper page
  55. Oxenoid, 2007, Comparing the structure and dynamics of phospholamban pentamer in its unphosphorylated and pseudo-phosphorylated states, Protein Sci., 16, 1977, 10.1110/ps.072975107 · doi:10.1110/ps.072975107
  56. Petrek, 2007, MOLE: a Voronoi diagram-based explorer of molecular channels, pores, and tunnels, Structure, 15, 1357, 10.1016/j.str.2007.10.007 · DOI · Paper page
  57. Pollesello, 2002, Structure of the 1-36 N-terminal fragment of human phospholamban phosphorylated at Ser-16 and Thr-17, Biophys. J., 83, 484, 10.1016/S0006-3495(02)75184-9 · doi:10.1016/s0006-3495(02)75184-9
  58. Said, 2003, Role of dual-site phospholamban phosphorylation in the stunned heart: insights from phospholamban site-specific mutants, Am. J. Physiol. Heart Circ. Physiol., 285, H1198, 10.1152/ajpheart.00209.2003 · doi:10.1152/ajpheart.00209.2003
  59. Schwieters, 2003, The Xplor-NIH NMR molecular structure determination package, J. Magn. Reson., 160, 65, 10.1016/S1090-7807(02)00014-9 · DOI · Paper page
  60. Senes, 2007, E(z), a depth-dependent potential for assessing the energies of insertion of amino acid side-chains into membranes: derivation and applications to determining the orientation of transmembrane and interfacial helices, J. Mol. Biol., 366, 436, 10.1016/j.jmb.2006.09.020 · DOI · Paper page
  61. Shen, 2009, TALOS+: a hybrid method for predicting protein backbone torsion angles from NMR chemical shifts, J. Biomol. NMR, 44, 213, 10.1007/s10858-009-9333-z · DOI · Paper page
  62. Shi, 2009, A refinement protocol to determine structure, topology, and depth of insertion of membrane proteins using hybrid solution and solid-state NMR restraints, J. Biomol. NMR, 44, 195, 10.1007/s10858-009-9328-9 · DOI
  63. Simmerman, 1998, Phospholamban: protein structure, mechanism of action, and role in cardiac function, Physiol. Rev., 78, 921, 10.1152/physrev.1998.78.4.921 · DOI · Paper page
  64. Simmerman, 1996, A leucine zipper stabilizes the pentameric membrane domain of phospholamban and forms a coiled-coil pore structure, J. Biol. Chem., 271, 5941, 10.1074/jbc.271.10.5941 · DOI · Paper page
  65. Smeazzetto, 2011, Phospholamban generates cation selective ion channels, Phys. Chem. Chem. Phys., 13, 12935, 10.1039/c1cp20460b · doi:10.1039/c1cp20460b
  66. Smeazzetto, 2013, Structure-function relation of phospholamban: modulation of channel activity as a potential regulator of SERCA activity, PLoS ONE, 8, e52744, 10.1371/journal.pone.0052744 · doi:10.1371/journal.pone.0052744
  67. Straus, 2011, Consensus structure of Pf1 filamentous bacteriophage from X-ray fibre diffraction and solid-state NMR, Eur. Biophys. J., 40, 221, 10.1007/s00249-010-0640-9 · DOI
  68. Subiros-Funosas, 2008, PyClock, the phosphonium salt derived from 6-Cl-HOBt, Chimica Oggi, 26, 10
  69. Tada, 1975, Phosphorylation of a 22,000-dalton component of the cardiac sarcoplasmic reticulum by adenosine 3′:5′-monophosphate-dependent protein kinase, J. Biol. Chem., 250, 2640, 10.1016/S0021-9258(19)41650-5 · DOI · Paper page
  70. Takegoshi, 2001, 13C-1H dipolar-assisted rotational resonance in magic-angle spinning NMR, Chem. Phys. Lett., 344, 631, 10.1016/S0009-2614(01)00791-6 · DOI · Paper page
  71. Teixeira, 2002, The use of DODT as a non-malodorous scavenger in Fmoc-based peptide synthesis, Protein Pept. Lett., 9, 379, 10.2174/0929866023408481 · DOI
  72. Terzi, 1992, Evidence for a phosphorylation-induced conformational change in phospholamban cytoplasmic domain by CD analysis, FEBS Lett., 309, 413, 10.1016/0014-5793(92)80819-3 · DOI
  73. Traaseth, 2007, Spectroscopic validation of the pentameric structure of phospholamban, Proc. Natl. Acad. Sci. USA, 104, 14676, 10.1073/pnas.0701016104 · DOI · Paper page
  74. Traaseth, 2008, Structural and dynamic basis of phospholamban and sarcolipin inhibition of Ca(2+)-ATPase, Biochemistry, 47, 3, 10.1021/bi701668v · DOI
  75. Traaseth, 2008, Asymmetric methyl group labeling as a probe of membrane protein homo-oligomers by NMR spectroscopy, J. Am. Chem. Soc., 130, 2400, 10.1021/ja711499r · DOI
  76. Traaseth, 2009, Structure and topology of monomeric phospholamban in lipid membranes determined by a hybrid solution and solid-state NMR approach, Proc. Natl. Acad. Sci. USA, 106, 10165, 10.1073/pnas.0904290106 · DOI · Paper page
  77. Tsien, 1987, Calcium channels: mechanisms of selectivity, permeation, and block, Annu. Rev. Biophys. Biophys. Chem., 16, 265, 10.1146/annurev.bb.16.060187.001405 · DOI · Paper page
  78. van der Wel, 2002, Geometry and intrinsic tilt of a tryptophan-anchored transmembrane α-helix determined by (2)H NMR, Biophys. J., 83, 1479, 10.1016/S0006-3495(02)73918-0 · DOI · Paper page
  79. Veglia, 2010, What can we learn from a small regulatory membrane protein?, Methods Mol. Biol., 654, 303, 10.1007/978-1-60761-762-4_16 · doi:10.1007/978-1-60761-762-4_16
  80. Verardi, 2011, Structural topology of phospholamban pentamer in lipid bilayers by a hybrid solution and solid-state NMR method, Proc. Natl. Acad. Sci. USA, 108, 9101, 10.1073/pnas.1016535108 · DOI · Paper page
  81. Verardi, 2012, Isotope labeling for solution and solid-state NMR spectroscopy of membrane proteins, Adv. Exp. Med. Biol., 992, 35, 10.1007/978-94-007-4954-2_3 · DOI
  82. Vostrikov, 2011, On the combined analysis of 2H and 15N/1H solid-state NMR data for determination of transmembrane peptide orientation and dynamics, Biophys. J., 101, 2939, 10.1016/j.bpj.2011.11.008 · doi:10.1016/j.bpj.2011.11.008
  83. Vostrikov, 2011, Gramicidin A backbone and side chain dynamics evaluated by molecular dynamics simulations and nuclear magnetic resonance experiments. II: nuclear magnetic resonance experiments, J. Phys. Chem. B, 115, 7427, 10.1021/jp200906y · doi:10.1021/jp200906y
  84. Vuister, 1994, 2D and 3D NMR study of phenylalanine residues in proteins by reverse isotopic labeling, J. Am. Chem. Soc., 116, 9206, 10.1021/ja00099a041 · DOI
  85. Walters, 2006, Helix-packing motifs in membrane proteins, Proc. Natl. Acad. Sci. USA, 103, 13658, 10.1073/pnas.0605878103 · DOI · Paper page
  86. Wang, 2000, Imaging membrane protein helical wheels, J. Magn. Reson., 144, 162, 10.1006/jmre.2000.2037 · DOI · Paper page
  87. Wegener, 1984, Phosphorylation-induced mobility shift in phospholamban in sodium dodecyl sulfate-polyacrylamide gels. Evidence for a protein structure consisting of multiple identical phosphorylatable subunits, J. Biol. Chem., 259, 1834, 10.1016/S0021-9258(17)43484-3 · doi:10.1016/s0021-9258(17)43484-3
  88. Wu, 1994, High-resolution heteronuclear dipolar solid-state NMR spectroscopy, J. Magn. Reson. A, 109, 270, 10.1006/jmra.1994.1169 · DOI · Paper page
  89. Yang, 2002, Structural analysis, identification, and design of calcium-binding sites in proteins, Proteins, 47, 344, 10.1002/prot.10093 · DOI
  90. Zamoon, 2003, NMR solution structure and topological orientation of monomeric phospholamban in dodecylphosphocholine micelles, Biophys. J., 85, 2589, 10.1016/S0006-3495(03)74681-5 · DOI

Cited by

Metadata

Authors
Vostrikov, V. V., Mote, K. R., Verardi, R., & Veglia, G.
Venue
Structure
Publisher
Elsevier BV
Published
2013-12
Volume
21
Issue
12
Pages
2119-2130
ISSN
0969-2126
Cited by
40
References
1
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.